A2 Milk sinks 11% as FDA defers new approvals

A2 Milk sinks 11% as FDA defers new approvals
Market disappointed with A2 news. (Image: Getty)
Rebecca Howard
A2 Milk sank 11% on news it won’t be sending infant formula to the lucrative US market any time soon.According to the company, the US Food and Drug Administration (FDA) is deferring further consideration of the company’s request for enforcement discretion to import infant milk formula products into the US.Last week, the company's shares jumped on an Australian news report that approval might be imminent. While A2 Milk moved quickly to dampen those expectations, the shares remained elevated, peaking at $5.64 on Friday.They recent...

More Primary Sector

Zespri on track for 'moderate increase' in volume next year
Primary Sector

Zespri on track for 'moderate increase' in volume next year

Zespri's producer vote to expand global supply passed this week.

Riley Kennedy 12 Dec 2024
Yashili NZ revenue dropped 42%
Primary Sector

Yashili NZ revenue dropped 42%

The Chinese-owned dairy processor’s accounts were due in May.

Riley Kennedy 12 Dec 2024
Zespri growers vote in favour of expanding global supply
Primary Sector

Zespri growers vote in favour of expanding global supply

Zespri’s growers have voted to support the expansion of the kiwifruit marketer’s global supply.A total of 90.6% of voting growers and 93.3% by fruit weight voted in favour of the resolution, which will allocate up to 420 hectares of SunGold fruit per year over six years in Italy,...

Riley Kennedy 11 Dec 2024